Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADC

Anti-amyloid antibodies for the treatment of Alzheimer´s disease (AD) are currently being evaluated for approval and reimbursement in Europe. An approval brings opportunities, but also challenges to health care systems across Europe. The objective of this position paper is to provide guidance from e...

Full description

Bibliographic Details

Main Authors:	Frederiksen, Kristian Steen (Author) , Boada, Mercé (Author) , Dubois, Bruno (Author) , Engelborghs, Sebastiaan (Author) , Frisoni, Giovanni B. (Author) , Georges, Jean (Author) , Hort, Jakub (Author) , Jönsson, Linus (Author) , Kramberger, Milica G. (Author) , Ousset, Pierre-Jean (Author) , Scarmeas, Nikolaos (Author) , Schmidt, Reinhold (Author) , Schott, Jonathan M. (Author) , Spiro, Luiza (Author) , Waldemar, Gunhild (Author) , Winblad, Bengt (Author) , Jessen, Frank (Author) , Frölich, Lutz (Author)
Format:	Article (Journal)
Language:	English
Published:	24 May 2025
In:	Alzheimer's research & therapy Year: 2025, Volume: 17, Pages: 1-9
ISSN:	1758-9193
DOI:	10.1186/s13195-025-01766-y
Online Access:	Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13195-025-01766-y Verlag, kostenfrei, Volltext: https://alzres.biomedcentral.com/articles/10.1186/s13195-025-01766-y
Author Notes:	Kristian S. Frederiksen, Mercé Boada, Bruno Dubois, Sebastiaan Engelborghs, Giovanni B. Frisoni, Jean Georges, Jakub Hort, Linus Jönsson, Milica G. Kramberger, Pierre-Jean Ousset, Nikolaos Scarmeas, Reinhold Schmidt, Jonathan M. Schott, Luiza Spiro, Gunhild Waldemar, Bengt Winblad, Frank Jessen and Lutz Frölich